Axon 1876
CAS [1076196-38-7 ]
MF C11H20Br2N2OMW 356.10
Excellent derivatisation reagent for aldehydes, yielding adducts with LC-MS-tuned identifiers and properties. Very mild derivatisation conditions (NaBH3CN, water, pH 5.7, 4 °C). Attractive selectivity profile (including over ketones) and specific fragmentation properties in MS/MS profiling sensitivity and specificity.* Sold in collaboration with VU (VU University Amsterdam)
Eggink M, Charret S, Wijtmans M, Lingeman H, Kool J, Niessen WM, Irth H. Development of an on-line weak-cation exchange liquid chromatography-tandem mass spectrometric method for (...). J Chromatogr B 2009, 877(31), 3937-3945. |
Eggink M, Wijtmans M, Ekkebus R, Lingeman H, de Esch IJ, Kool J, Niessen WM, Irth H. Development of a selective ESI-MS derivatization reagent: synthesis and optimization for the analysis of aldehydes (...). Anal Chem. 2008, 80(23), 9042-9051. |
4-(2-(trimethylammonio)ethoxy)benzenaminium bromide
[76201-92-8]
Axon Medchem的业务之一,是独有的Axon Ligands配体库,在世界范围内,被认为是药物研发的标准。这其中,针对850余种生物靶标(包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等),Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库,Axon Medchem还是欧洲著名的CRO公司,主要针对生物活性分子和药物类似分子展开合成及协议开发工作,在过去的10年中,Axon Medchem已经发现了多种潜在药物分子,并在生物医药界享有一定的声誉。